epicutantest-trolab[r] d2366 2-ethylhexyl-4-metoxycinnamat 10% salbe
smartpractice europe gmbh - octinoxat - salbe - octinoxat 10% (m/v)
uman albumin kedrion 20% uman albumin kedrion 20%
kedrion swiss sarl - uman albumin kedrion 20%
uman albumin kedrion 25% uman albumin kedrion 25%
kedrion swiss sarl - uman albumin kedrion 25%
cueva
gns consult ag - kupfer (als octanoat) - scsuspensionskonzentrat - 1.74 %18.2 g/l; [als 9.57 % kupfer-octanoat]; - fungizid ;
skinoren 20 % - creme
leo pharma a/s - azelainsÄure - azelainsäure
maviret filmtabletten maviret filmtabletten
abbvie ag - glecaprevirum, pibrentasvirum - maviret filmtabletten - glecaprevirum 100 mg, pibrentasvirum 40 mg, copovidonum k 28, tocofersolanum, silica colloidalis anhydrica, propylenglycoli monooctanoas, carmellosum natricum conexum, natrii stearylis fumaras, Überzug: hypromellosum, lactosum monohydricum 7.87 mg, macrogolum 3350, e 171, e 172 (rubrum), pro compresso obducto corresp. natrium 2.6 mg. - chronische hepatitis c - synthetika
pigmanorm creme
louis widmer ag - hydrochinonum, tretinoinum, dexamethasonum - creme - hydrochinonum 50 mg, tretinoinum 0.3 mg, dexamethasonum 0.3 mg, propylenglycolum 70.4 mg, glyceroli monostearas 40-55, natrii cetylo- et stearylosulfas, paraffinum liquidum, isopropylis myristas, vaselinum album, octinoxatum, avobenzonum, alcohol cetylicus 15 mg, dexpanthenolum, ethanolum, dextrocamphora, e 171, sorbitolum liquidum non cristallisabile, int-rac-alpha-tocopherylis acetas, acidum citricum monohydricum, acidum ascorbicum, e 218 1.5 mg, propylis parahydroxybenzoas 500 µg, acidum lacticum, dinatrii edetas, e 320 40 µg, e 321 40 µg, aqua purificata, ad unguentum pro 1 g. - umschriebene formen von melaninbedingten hyperpigmentierungen - synthetika
spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - impfstoffe - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.
xinca suspensionskonzentrat
nufarm deutschland gmbh - 401,6 g/l bromoxynil (493,5 g/l butyrat + (octanoat + phenol als kristallisationshemmer)) - suspensionskonzentrat - 401,6 g/l bromoxynil (493,5 g/l butyrat + (octanoat + phenol als kristallisationshemmer)) - herbizid
xinca [bewilligung beendet / autorisation révoquée / autorizzazione revocata: ausverkaufsfrist / délai d'écoulement des sto
nufarm suisse sàrl - bromoxynil - scsuspensionskonzentrat - 32.5 %402 g/l; [als 39.1 % bromoxynil-butryrat (483 g/l), 0.98 % bromxynil-octanoat (12.1 g/l) und 0.68 % bromoxynil (8.4 g/l)]; - herbizid ;